Cardium Therapeutics today announced the availability of MedPodium Nutra-Apps™, small, pharmaceutically-sealed, tasteless, easy-use capsules in pocket-sized packaging that are designed to address the unique needs of today’s highly mobile and technology-driven millennial consumers (aged 20-35).…
Cardium Therapeutics, a company focused on acquiring and developing new biomedical products, today announced it has received clearance from the Russian Ministry of Health and Social Development to start the phase III registration study for…
CXM is a requested video chart and a lesson in technical analysis. While some of the indicators are bearish, the chart is still a viable play as it is holding a nice double bottom at…
Cardium Therapeutics Inc. acquires and strategically develops new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other opportunities for…